Biomarkers for Systemic Therapy in Ovarian Cancer

E-ISSN： 1873-5576|14|3|259-273

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.3, 2014-03, pp. : 259-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian Cancer Biomarkers: Current Options and Future Promise

By Coticchia Christine M. Yang Jiang Moses Marsha A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 8, 2008-09 ,pp. : 795-802

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

By Góómez-Raposo Céésar Mendiola Marta Barriuso Jorge Hardisson David Redondo Andréés

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy for epithelial ovarian cancer

By Sharma Sameer Odunsi Kunle

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite

The potential of sunitinib as a therapy in ovarian cancer

By Leone Roberti Maggiore Umberto Valenzano Menada Mario Venturini Pier Luigi Ferrero Simone

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1671-1686

Informa Healthcare

Access to resources Recommend Favorite

Targeted Gene Therapy for Ovarian Cancer

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 643-653

Bentham Science Publishers

Access to resources Recommend Favorite